Viral fusion inhibitor
This page covers all Viral fusion inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Viral hemagglutinin (envelope protein).
Targets
Viral hemagglutinin (envelope protein)
Marketed (1)
- Arbidol (Umifenovir) · Pharmstandard · Infectious Disease / Virology
Arbidol inhibits viral fusion by blocking the interaction between viral envelope proteins and host cell membranes, preventing viral entry into cells.
Patent intelligence
- viral fusion inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates